login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
LARIMAR THERAPEUTICS INC (LRMR) Stock News
USA
- NASDAQ:LRMR -
US5171251003
-
Common Stock
3.47
USD
+0.08 (+2.36%)
Last: 11/19/2025, 2:57:50 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LRMR Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Chartmill
- Mentions:
HP
MDXG
APYX
APLT
...
What's going on in today's after hours session
15 days ago - By: Larimar Therapeutics
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
20 days ago - By: The Rosen Law Firm, P.A.
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
22 days ago - By: Schall Law
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
23 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
a month ago - By: The Rosen Law Firm, P.A.
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
a month ago - By: DJS Law Group
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
a month ago - By: The Schall Law Firm
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
a month ago - By: Benzinga
- Mentions:
IVA
IP
IVR
NAT
...
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
2 months ago - By: Benzinga
- Mentions:
DH
HCTI
FBIO
PALI
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
2 months ago - By: Stocktwits
- Mentions:
URTY
IWV
Larimar Therapeutics Stock Slumps Pre-market Over High Anaphylaxis Rate In Drug Study
2 months ago - By: Larimar Therapeutics
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
2 months ago - By: Larimar Therapeutics
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
3 months ago - By: The Motley Fool
Larimar Beats Q2 Loss Estimates
3 months ago - By: Larimar Therapeutics
Larimar Therapeutics Reports Second Quarter 2025 Financial Results
4 months ago - By: Larimar Therapeutics
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
4 months ago - By: Larimar Therapeutics
Larimar Therapeutics Announces Pricing of Underwritten Public Offering
4 months ago - By: Larimar Therapeutics
Larimar Therapeutics Announces Proposed Underwritten Public Offering
Please enable JavaScript to continue using this application.